Could a common allergy pill boost lung cancer treatment?
NCT ID NCT07358689
Summary
This study is testing if adding an over-the-counter allergy medication (diphenhydramine) to standard chemotherapy and immunotherapy improves results for people with operable non-small cell lung cancer. About 120 participants will receive the drug combination before surgery and then continue maintenance therapy for over a year afterward. The main goal is to see if this approach helps eliminate more cancer cells in the removed tumor and improves long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.